Baakman AC, t Hart E, Kay DG, Stevens J, Klaassen ES, Maelicke A, Groeneveld GJ (2016) <br />First in human study with a prodrug of galantamine: Improved benefit-risk ratio?<br /><i>Alzheimers Dement (N Y)</i> <b>2</b>: 13<br /><br />Bhattacharya S, Maelicke A, Montag D (2015) <br />Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice<br /><i>J Alzheimers Dis</i> <b>46</b>: 123<br /><br />Maelicke A, Hoeffle-Maas A, Ludwig J, Maus A, Samochocki M, Jordis U, Koepke AK (2010) <br />Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy<br /><i>Journal of Molecular Neuroscience</i> <b>40</b>: 135<br /><br />